Bristol-Myers Squibb BMY
$61.83 −$0.31 (-0.49%)
Market open · Nov 10, 9:40 am ET · After hours $62.43 +0.47%
Open$61.75
Prev close$62.14
Day range$61.42 – $62.13
Volume274.5K
Market cap$126.40B
P/E (TTM)13.7
Dividend yield4.08%
Earnings
Average move on report day±4.3%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+11.4%
Worst reaction-8.5%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | Pre Market | ±3.5% | +1.35% | Within range |
| 2026/Q2 | 30 Jul 2026 | Pre Market | ±3.2% | +2.79% | Within range |
| 2026/Q1 | 30 Apr 2026 | Pre Market | ±4.0% | +5.21% | Bigger than priced |
| 2025/Q4 | 5 Feb 2026 | Pre Market | ±3.7% | +3.30% | Within range |
| 2025/Q3 | 30 Oct 2025 | Pre Market | ±4.3% | +7.09% | Bigger than priced |
| 2025/Q2 | 31 Jul 2025 | Pre Market | ±4.9% | -5.81% | Bigger than priced |
| 2025/Q1 | 24 Apr 2025 | None | ±5.3% | +0.33% | Within range |
| 2024/Q4 | 6 Feb 2025 | None | ±5.6% | -3.84% | Within range |
| 2024/Q3 | 31 Oct 2024 | Pre Market | ±4.5% | +5.91% | Bigger than priced |
| 2024/Q2 | 26 Jul 2024 | Pre Market | ±6.0% | +11.44% | Bigger than priced |
| 2024/Q1 | 25 Apr 2024 | Pre Market | ±3.6% | -8.51% | Bigger than priced |
| 2023/Q4 | 2 Feb 2024 | Pre Market | ±5.1% | +0.08% | Within range |
| 2023/Q3 | 26 Oct 2023 | Pre Market | ±3.0% | -6.43% | Bigger than priced |
| 2023/Q2 | 27 Jul 2023 | Pre Market | ±3.0% | -4.23% | Bigger than priced |
| 2023/Q1 | 27 Apr 2023 | Pre Market | ±3.0% | -0.60% | Within range |
| 2022/Q4 | 2 Feb 2023 | Pre Market | ±3.3% | +2.16% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$13.07B+6.9% YoY
Operating profit$4.40B+20.9% YoY
Net profit$2.16B-1.5% YoY
Diluted EPS$1.05-2.8% YoY
Free cash flow$3.84B-36.0% YoY
Operating cash flow$4.18B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin69.2%
Operating margin29.2%
Net margin18.5%
Return on equity44.1%
Return on assets10.0%
Return on invested capital15.4%
Current ratio1.59
Liabilities / assets73.6%
Cash & investments$12.58B
Total debt$44.59B
Net cash (debt)-$32.01B
Free cash flow / sales18.6%
No comments yet — be the first to weigh in on BMY.
Sign in to join the discussion.